Literature DB >> 21725509

Endosonographic tumor staging for treatment decision in resectable gastric cancer.

Wolfram Bohle1, Alexander Scheidig, Wolfram G Zoller.   

Abstract

BACKGROUND AND AIMS: Neoadjuvant preoperative chemotherapy is the standard of care in locally advanced resectable gastric cancer. Therefore, accurate locoregional staging is essential for treatment decision. EUS is believed to be the most performant diagnostic method for locoregional staging. However, it is questionable, if results from centers of excellence can be maintained in clinical routine.
METHODS: We retrospectively analyzed the data of 62 resectable gastric cancers staged by EUS during routine clinical work-up. Preoperative variables (tumor size and site, histological differentiation) were compared with the postoperative pathology.
RESULTS: 19 locally limited (T1-2, N0), and 43 locally advanced (T3-4, or N+ irrespective of T stage) were analyzed. The sensitivity of EUS for the detection of locally advanced disease was 93%, with a specificity of 78%.
CONCLUSIONS: Even in daily routine practice, differentiation of locally limited and advanced disease with EUS can be performed with high sensitivity and good specificity. Therefore, EUS is an essential part of the diagnostic procedure in patients with gastric cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21725509

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  6 in total

1.  Endoscopic ultrasound-guided deep and large biopsy for diagnosis of gastric infiltrating tumors with negative malignant endoscopy biopsies.

Authors:  Xin-Xin Zhou; Hang-Hai Pan; Ali Usman; Feng Ji; Xi Jin; Wei-Xiang Zhong; Hong-Tan Chen
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.

Authors:  Simone Mocellin; Sandro Pasquali
Journal:  Cochrane Database Syst Rev       Date:  2015-02-06

3.  Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Kazunori Fugo; Takafumi Sunaoshi; Daisuke Kano; Satomi Tanaka; Aika Ozaki; Eriko Sugiyama; Misaki Shite; Ryouta Haga; Akira Baba; Yoshiya Fukamizu; Toshiyuki Fujita; Satoshi Kagayama; Rumiko Hasegawa; Akira Togawa; Yoshinori Shirai; Noboru Ichiki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Mol Clin Oncol       Date:  2016-05-11

4.  The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine.

Authors:  Seyyed-Hossein Yahyazadeh-Jabbari; Nasser Malekpour; Bahram Salmanian; Hossein Foodazi; Masoud Salehi; Farsad Noorizadeh
Journal:  Iran J Cancer Prev       Date:  2013

5.  A Meta-Analysis And Systematic Review Of Accuracy Of Endoscopic Ultrasound For N Staging Of Gastric Cancers.

Authors:  Jiafei Chen; Chaoyang Zhou; Min He; Zhiming Zhen; Jie Wang; Xiaofei Hu
Journal:  Cancer Manag Res       Date:  2019-09-27       Impact factor: 3.989

6.  Gastric cancer staging with dual energy spectral CT imaging.

Authors:  Zilai Pan; Lifang Pang; Bei Ding; Chao Yan; Huan Zhang; Lianjun Du; Baisong Wang; Qi Song; Kemin Chen; Fuhua Yan
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.